U
DGX icon

UBS’s Quest Diagnostics DGX Stock Holding History

UBS’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$158K Sell
2,600
-11,300
-81% -$696K ﹤0.01% 5444
2014
Q2 		$816K Buy
13,900
+12,500
+893% +$732K ﹤0.01% 3750
2014
Q1 		$81K Sell
1,400
-3,200
-70% -$172K ﹤0.01% 6251
2013
Q4 		$246K Buy
4,600
+3,400
+283% +$202K ﹤0.01% 5074
2013
Q3 		$74K Sell
1,200
-4,000
-77% -$239K ﹤0.01% 6357
2013
Q2 		$315K Buy
+5,200
New +$310K ﹤0.01% 4586

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

UBS's DGX Position: Q3 2014 in Review

UBS reduced its Quest Diagnostics (DGX) stake by 34% in Q3 2014, selling an estimated $2.45M and leaving 78,680 shares worth $4.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

UBS first reported a position in DGX in Q2 2013 and has held it in 6 quarters since. The position peaked at $22.6M in Q3 2013. 485 funds tracked by Wall St. Rank hold DGX as of Q3 2014.

  • UBS held 78,680 shares of Quest Diagnostics worth $4.77M as of Q3 2014.
  • UBS sold 39,800 Quest Diagnostics shares in Q3 2014, an estimated $2.45M.
  • Quest Diagnostics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2081 holding.
  • UBS first reported a position in Quest Diagnostics in Q2 2013 and has held it in 6 quarters since.
  • UBS's Quest Diagnostics position peaked at $22.6M in Q3 2013.
  • 485 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.